These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 37773451)
1. Clinical impact of mixed pulmonary carcinoma and carcinoid: the driver from their mono-clonal origin. Graziano P; Parente P; Centra F; Milione M; Centonze G; Volante M; Cavazza A; Urbano D; Di Maggio G; Balsamo T; Di Micco C; Rossi G; Rossi A; Muscarella LA Virchows Arch; 2024 Jan; 484(1):37-46. PubMed ID: 37773451 [TBL] [Abstract][Full Text] [Related]
2. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922 [TBL] [Abstract][Full Text] [Related]
3. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization. Walch AK; Zitzelsberger HF; Aubele MM; Mattis AE; Bauchinger M; Candidus S; Präuer HW; Werner M; Höfler H Am J Pathol; 1998 Oct; 153(4):1089-98. PubMed ID: 9777940 [TBL] [Abstract][Full Text] [Related]
4. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Travis WD; Rush W; Flieder DB; Falk R; Fleming MV; Gal AA; Koss MN Am J Surg Pathol; 1998 Aug; 22(8):934-44. PubMed ID: 9706973 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901). Peng W; Cao L; Chen L; Lin G; Zhu B; Hu X; Lin Y; Zhang S; Jiang M; Wang J; Li J; Li C; Shao L; Du H; Hou T; Chen Z; Xiang J; Pu X; Li J; Xu F; Loong H; Wu L Oncologist; 2022 Mar; 27(2):e116-e125. PubMed ID: 35641209 [TBL] [Abstract][Full Text] [Related]
6. Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D. Simbolo M; Mafficini A; Sikora KO; Fassan M; Barbi S; Corbo V; Mastracci L; Rusev B; Grillo F; Vicentini C; Ferrara R; Pilotto S; Davini F; Pelosi G; Lawlor RT; Chilosi M; Tortora G; Bria E; Fontanini G; Volante M; Scarpa A J Pathol; 2017 Mar; 241(4):488-500. PubMed ID: 27873319 [TBL] [Abstract][Full Text] [Related]
7. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?]. Schnabel PA; Junker K Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813 [TBL] [Abstract][Full Text] [Related]
8. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets. Rekhtman N; Pietanza MC; Hellmann MD; Naidoo J; Arora A; Won H; Halpenny DF; Wang H; Tian SK; Litvak AM; Paik PK; Drilon AE; Socci N; Poirier JT; Shen R; Berger MF; Moreira AL; Travis WD; Rudin CM; Ladanyi M Clin Cancer Res; 2016 Jul; 22(14):3618-29. PubMed ID: 26960398 [TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Travis WD; Linnoila RI; Tsokos MG; Hitchcock CL; Cutler GB; Nieman L; Chrousos G; Pass H; Doppman J Am J Surg Pathol; 1991 Jun; 15(6):529-53. PubMed ID: 1709558 [TBL] [Abstract][Full Text] [Related]
10. Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung. Liu SZ; Staats PN; Goicochea L; Alexiev BA; Shah N; Dixon R; Burke AP Diagn Pathol; 2014 Oct; 9():174. PubMed ID: 25318848 [TBL] [Abstract][Full Text] [Related]
13. A case of a primary lung cancer comprised of adenocarcinoma and atypical carcinoid tumor with both components harboring BRAF p.V600E mutation. Olofson AM; Tafe LJ Exp Mol Pathol; 2018 Feb; 104(1):26-28. PubMed ID: 29248665 [TBL] [Abstract][Full Text] [Related]
14. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases. Jiang SX; Kameya T; Shoji M; Dobashi Y; Shinada J; Yoshimura H Am J Surg Pathol; 1998 May; 22(5):526-37. PubMed ID: 9591721 [TBL] [Abstract][Full Text] [Related]
15. Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors. Asiedu MK; Thomas CF; Dong J; Schulte SC; Khadka P; Sun Z; Kosari F; Jen J; Molina J; Vasmatzis G; Kuang R; Aubry MC; Yang P; Wigle DA Clin Cancer Res; 2018 Apr; 24(7):1691-1704. PubMed ID: 29351916 [No Abstract] [Full Text] [Related]
17. Downregulation of drs tumor suppressor gene in highly malignant human pulmonary neuroendocrine tumors. Shimakage M; Kodama K; Kawahara K; Kim CJ; Ikeda Y; Yutsudo M; Inoue H Oncol Rep; 2009 Jun; 21(6):1367-72. PubMed ID: 19424611 [TBL] [Abstract][Full Text] [Related]
18. [Diagnosis of lung biopsy employing the 2015 WHO criteria and detection of related oncogenic driver mutations]. Fang F; Qiao XB; Yang L; Di J; Hu ST; Liu DG; Lyu N Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):270-275. PubMed ID: 30955261 [No Abstract] [Full Text] [Related]
19. Pulmonary neuroendocrine tumors: study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses. Yeh YC; Chou TY J Surg Oncol; 2014 Mar; 109(3):280-6. PubMed ID: 24301337 [TBL] [Abstract][Full Text] [Related]